RE: Mologic5 May 2020 19:59
"Our consortium includes a globally distributed testing network across four
continents to evaluate novel RDTs in Malaysia, Kenya, Malawi, China, Spain, North
America, and Latin America".
Remember the test doesn't have to meet the UK specificity/sensitivity specifications, as Mologic is prioritizing nations without strong healthcare infrastructure.